{"@context":"https://neupai.io/schema/v0.2","@type":"StructuredNewsArticle","identity":{"article_id":"news.samsung.com_20261020_element-biosciences-seoul-roadshow","canonical_url":"https://news.samsung.com/kr/%ec%82%bc%ec%84%b1%ec%a0%84%ec%9e%90%ea%b0%80-%ed%88%ac%ec%9e%90%ed%95%9c-%e7%be%8e-%ec%97%98%eb%a6%ac%eb%a8%bc%ed%8a%b8-%eb%b0%94%ec%9d%b4%ec%98%a4%ec%82%ac%ec%9d%b4%ec%96%b8%ec%8a%a4%e7%a4%be","ai_url":null,"publisher":{"name":"삼성전자 뉴스룸","domain":"news.samsung.com","type":"online"},"author":"삼성전자 뉴스룸","published_at":"2026-10-20T08:19:04.000Z","updated_at":null,"language":"en","article_type":"press_release_based","originality":"press_release_rewrite"},"content":{"headline":"Element Biosciences, U.S. Firm Backed by Samsung Electronics, Hosts Global Roadshow ‘Shift Your Science’ in Seoul","summary":"Element Biosciences, a U.S. genomic analysis company in which Samsung Electronics is the largest shareholder, will hold a roadshow in Seoul on October 20 to introduce its latest sequencing device ‘Vitari’ and multi-omics solution ‘Cytos.’ Samsung Electronics secured its status as the largest shareholder by making an additional investment of $175 million last June, and plans to explore business opportunities in the precision medicine field.","topics":["bio","genomics","investment","medical devices","precision medicine"],"geography":["KR","US"],"entities":[{"name":"Samsung Electronics","canonical_id":"corp:kr:samsung-electronics","type":"company","role_in_article":"primary_subject","metadata":{"ticker":"005930.KS","parent":null}},{"name":"Element Biosciences","canonical_id":"corp:us:element-biosciences","type":"company","role_in_article":"primary_subject","metadata":{"ticker":null,"parent":null}},{"name":"Molly He","canonical_id":"person:us:molly-he","type":"person","role_in_article":"quoted","metadata":{"ticker":null,"parent":null}},{"name":"Michael Previte","canonical_id":"person:us:michael-previte","type":"person","role_in_article":"mentioned","metadata":{"ticker":null,"parent":null}},{"name":"Vitari","canonical_id":"product:us:vitari","type":"product","role_in_article":"mentioned","metadata":{"ticker":null,"parent":"corp:us:element-biosciences"}},{"name":"Cytos","canonical_id":"product:us:cytos","type":"product","role_in_article":"mentioned","metadata":{"ticker":null,"parent":"corp:us:element-biosciences"}},{"name":"AVITI","canonical_id":"product:us:aviti","type":"product","role_in_article":"mentioned","metadata":{"ticker":null,"parent":"corp:us:element-biosciences"}}],"claims":[{"id":"c1","statement":"Samsung Electronics participated in Element's 'Series D' investment in July 2024, and further secured its status as the largest shareholder by investing an additional $175 million in the 'Series E' round last June","as_of":"2026-06","as_of_explicit":false,"as_of_raw":"last June","source_type":"company_disclosure","comparison":null,"type":"fact","figures":{"value":175000000,"unit":"USD","approximate":false,"converted":null},"expiry_hint":null,"insight":null},{"id":"c2","statement":"Element possesses DNA sequencing technology that raises genomic analysis accuracy to an industry-leading 99.99% while significantly lowering analysis costs","as_of":"2026-10","as_of_explicit":false,"as_of_raw":"October 2026","source_type":"company_disclosure","comparison":null,"type":"fact","figures":{"value":99.99,"unit":"%","approximate":false,"converted":null},"expiry_hint":null,"insight":null},{"id":"c3","statement":"Since launching its mid-sized sequencing device 'AVITI' in 2022, Element has rapidly expanded its presence in the global market","as_of":"2022","as_of_explicit":true,"as_of_raw":"2022","source_type":"company_disclosure","comparison":null,"type":"fact","figures":null,"expiry_hint":null,"insight":null},{"id":"c4","statement":"Vitari increases analysis throughput by more than 5 times compared to existing products in a single run, and significantly reduces genomic analysis costs to $100 per person","as_of":"2026-10","as_of_explicit":false,"as_of_raw":"October 2026","source_type":"company_disclosure","comparison":"previous_product","type":"fact","figures":{"value":5,"unit":"x","approximate":false,"converted":null},"expiry_hint":null,"insight":null},{"id":"c5","statement":"Vitari is scheduled to begin shipping from late 2026","as_of":"2026","as_of_explicit":true,"as_of_raw":"late 2026","source_type":"company_plan","comparison":null,"type":"future_plan","figures":null,"expiry_hint":"2026-12","insight":null},{"id":"c6","statement":"Samsung Electronics plans to explore new business opportunities in the precision medicine field by combining its AI, medical device, and digital health capabilities with Element's genomic analysis and multi-omics technology","as_of":"2026-10","as_of_explicit":false,"as_of_raw":"October 2026","source_type":"company_plan","comparison":null,"type":"future_plan","figures":null,"expiry_hint":null,"insight":null}],"ai_emotional_context":{"valence":0.4,"arousal":0.3,"primary_emotions":[{"emotion":"optimistic","intensity":0.5}],"secondary_emotions":[{"emotion":"calm","intensity":0.3}],"emotional_triggers":[{"claim_id":"c1","emotion":"optimistic","reason":"major_opportunity"}]}},"provenance":{"source_chain":["press_release","samsung-electronics"],"original_source_url":null,"related_articles":[]},"temporal":{"freshness":"breaking","next_update_expected":null},"access":{"license":"neupai_standard","attribution_required":true,"structured_data":"free","full_text_available":true,"full_text_access":null}}